These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18230976)

  • 1. Cutaneous graft-versus-host disease: a guide for the dermatologist.
    Häusermann P; Walter RB; Halter J; Biedermann BC; Tichelli A; Itin P; Gratwohl A
    Dermatology; 2008; 216(4):287-304. PubMed ID: 18230976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening graft-vs-host disease.
    Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
    Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease: clinical manifestation and therapy.
    Ratanatharathorn V; Ayash L; Lazarus HM; Fu J; Uberti JP
    Bone Marrow Transplant; 2001 Jul; 28(2):121-9. PubMed ID: 11509929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
    Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
    Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS; Engemann AM; Hammond JM
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.
    Vogelsang GB; Lee L; Bensen-Kennedy DM
    Annu Rev Med; 2003; 54():29-52. PubMed ID: 12359826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular graft-versus-host disease: a review.
    Shikari H; Antin JH; Dana R
    Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GVHD pathophysiology: is acute different from chronic?
    Toubai T; Sun Y; Reddy P
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUVA therapy for chronic cutaneous graft-vs-host disease.
    Jampel RM; Farmer ER; Vogelsang GB; Wingard J; Santos GW; Morison WL
    Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of acute GvHD.
    Messina C; Faraci M; de Fazio V; Dini G; Calò MP; Calore E;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S65-70. PubMed ID: 18545247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-host disease of the skin: life and death on the epidermal edge.
    Hofmeister CC; Quinn A; Cooke KR; Stiff P; Nickoloff B; Ferrara JL
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):366-72. PubMed ID: 15148490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell immunity and graft-versus-host disease (GVHD).
    Ichiki Y; Bowlus CL; Shimoda S; Ishibashi H; Vierling JM; Gershwin ME
    Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
    Kline J; Subbiah S; Lazarus HM; van Besien K
    Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic graft-versus-host disease.
    Ross WA; Couriel D
    Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
    Auletta JJ; Cooke KR
    Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum.
    Schaffer JV; McNiff JM; Seropian S; Cooper DL; Bolognia JL
    J Am Acad Dermatol; 2005 Oct; 53(4):591-601. PubMed ID: 16198778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.